{"nct_id":"NCT05513053","title":"Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2022-10-27","start_date_type":"ACTUAL","primary_completion_date":"2023-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}